Insider · CIK 0001465825

Nigalaye Ashok G

CIK 0001465825 Name as filed on the most recent filing

Filed as Nigalaye Ashok G (18)

28 transaction lines · from 18 filings · filed 2011-03-17 to 2014-03-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

28 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2014-03-11 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 144,003, disposed Open Form 4 filing 0001053369-14-000026
2014-03-07 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 714,986, disposed Open Form 4 filing 0001465826-14-000003
2014-03-06 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 692,344, disposed Open Form 4 filing 0001465826-14-000003
2014-01-13 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 147,422, disposed Open Form 4 filing 0001053369-14-000013
2013-12-05 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 34,513, disposed Open Form 4 filing 0001442002-13-000002
2013-12-02 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 12,520, disposed Open Form 4 filing 0001053369-13-000061
2013-11-27 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 3,030, disposed Open Form 4 filing 0001053369-13-000057
2013-11-26 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 2,793, disposed Open Form 4 filing 0001442002-13-000002
2013-11-26 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 43,126, disposed Open Form 4 filing 0001053369-13-000057
2013-11-19 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 2,457, disposed Open Form 4 filing 0001465826-13-000003
2013-11-18 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 137,475, disposed Open Form 4 filing 0001465826-13-000003
2013-11-15 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 29,683, disposed Open Form 4 filing 0001053369-14-000003
2013-11-15 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 37,307, disposed Open Form 4 filing 0001465826-13-000003
2013-11-14 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 53,578, disposed Open Form 4 filing 0001465826-13-000003
2013-11-11 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 4,778, disposed Open Form 4 filing 0001053369-13-000057
2013-11-06 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 15,092, disposed Open Form 4 filing 0001053369-13-000053
2013-10-29 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 17,755, disposed Open Form 4 filing 0001053369-13-000049
2013-10-28 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 18,065, disposed Open Form 4 filing 0001053369-13-000049
2013-01-22 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 32,103, disposed Open Form 4 filing 0001053369-13-000012
2013-01-11 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 211,913, disposed Open Form 4 filing 0001053369-13-000003
2013-01-03 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 79,678, disposed Open Form 4 filing 0001053369-14-000009
2012-12-26 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 50,883, disposed Open Form 4 filing 0001053369-12-000011
2012-12-19 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 22,335, disposed Open Form 4 filing 0001053369-12-000007
2012-03-27 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 66,150, disposed Open Form 4 filing 0001345568-12-000024
2012-03-26 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 21,308, disposed Open Form 4 filing 0001345568-12-000024
2012-03-23 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 169,087, disposed Open Form 4 filing 0001345568-12-000024
2012-03-16 S, Open-market sale Elite Pharmaceuticals Inc /NV/ELTP 8,543, disposed Open Form 4 filing 0001345568-12-000011
2011-02-02 P, Open-market purchase Elite Pharmaceuticals Inc /DE/ELTP 16,318, acquired Open Form 4 filing 0001465825-11-000002

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 27
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. NIGALAYE ASHOK G, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001465825

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.